Improving drug delivery to pancreatic cancer: breaching the stromal fortress by targeting hyaluronic acid

Gut. 2012 Oct;61(10):1377-9. doi: 10.1136/gutjnl-2012-302604. Epub 2012 Jun 3.
No abstract available

MeSH terms

  • Animals
  • Antimetabolites, Antineoplastic / administration & dosage*
  • Antimetabolites, Antineoplastic / therapeutic use
  • Biomarkers, Tumor / metabolism*
  • Cell Adhesion Molecules / administration & dosage
  • Cell Adhesion Molecules / pharmacology
  • Deoxycytidine / administration & dosage
  • Deoxycytidine / analogs & derivatives*
  • Deoxycytidine / therapeutic use
  • Drug Delivery Systems*
  • Drug Resistance, Neoplasm* / drug effects
  • Drug Resistance, Neoplasm* / physiology
  • Gemcitabine
  • Humans
  • Hyaluronic Acid / metabolism*
  • Hyaluronoglucosaminidase / administration & dosage
  • Hyaluronoglucosaminidase / pharmacology
  • Mice
  • Pancreatic Neoplasms / drug therapy*
  • Pancreatic Neoplasms / metabolism
  • Recombinant Proteins / administration & dosage
  • Recombinant Proteins / pharmacology

Substances

  • Antimetabolites, Antineoplastic
  • Biomarkers, Tumor
  • Cell Adhesion Molecules
  • Recombinant Proteins
  • Deoxycytidine
  • Hyaluronic Acid
  • Hyaluronoglucosaminidase
  • hyaluronidase PH-20
  • Gemcitabine